Nanomedicine News

RSS

Toxicity Study Ensures Safety of Quantum Dots in Nanomedicine Applications

A multi-institute toxicity study on quantum dots in primates has discovered that these nanocrystals are safe for a period of one year.

22 May 2012

Study Findings Help Design Next-Generation Nanocarriers

Researchers believe that atomic-scale design of pharmaceuticals will be instrumental in producing more accurate and efficient drugs. Computer simulations developed by a team headed by Ravi Radhakrishnan from the University of Pennsylvania will be helpful in optimizing these designs.

19 May 2012

New Polymer Allows Improved Method for Preparation of Nanoparticles for Drug Delivery

Ainhoa Lejardi, an engineer at the UPV/EHU, has created a new polymer material which could improve the preparation of nanospheres for their use as a method of controlling the release of pharmaceuticals, research which is currently ongoing at the Spanish National Research Council in Madrid.

18 May 2012

Study Reveals DNA Nanoparticle Delivery System Itself has Therapeutic Value

A research team from the Georgia Health Sciences University has demonstrated that DNA nanoparticles, a DNA-wrapped submicroscopic delivery system for supplying drugs and genes straightaway into cells for disease treatment, show therapeutic value.

17 May 2012

Senesco to Deliver Presentation on eIF5A-Based Nanoparticle for Multiple Myeloma Treatment

Senesco Technologies will deliver an oral presentation titled ‘SNS01-T, an eIF5A-Based Gene Therapy Nanoparticle Designed for the Treatment of Multiple Myeloma, has Anti-Tumoral Activity in Lymphoma’ at the 15th Annual Meeting of the American Society of Gene & Cell Therapy.

16 May 2012

Alnylam Reports Final Phase I Clinical Study Results of Lipid Nanoparticle-Based ALN-TTR01

Tekmira Pharmaceuticals, a specialist in RNA interference (RNAi) therapeutics announced that Alnylam Pharmaceuticals has reported final results from its Phase I clinical study of an RNAi therapeutic for transthyretin (TTR) called ALN-TTR01 that uses Tekmira’s lipid nanoparticle delivery technology to treat TTR-mediated amyloidosis and is produced by Tekmira.

14 May 2012

New Report Predicts Nanocrystals Will Outperform Nanocarriers in Drug Delivery

Research and Markets has included a new report titled ‘Nanotechnology for Drug Delivery: Global Market for Nanocrystals’ to its database.

From Research and Markets 10 May 2012

Positive Phase 1 Clinical Results for Nanoformulated Midaform Insulin PharmFilm Product

MonoSol Rx, a provider of PharmFilm drug delivery technology, and Midatech, which produces nanomedicines using its passivated gold-nanoparticle technology, have released positive Phase 1 clinical study results on bioavailability and pharmacokinetics of their Midaform Insulin PharmFilm product.

5 May 2012

New Nanoparticles Can Deliver Large Doses of Antibiotics to Bacteria

A team of scientists from Massachusetts Institute of Technology and Brigham and Women’s Hospital has designed new nanoparticles that are capable of bypassing the immune system and entering into infection sites to deliver a targeted antibiotic attack.

From Massachusetts Institute of Technology 5 May 2012

Light Touch Keeps a Grip on Delicate Nanoparticles

Using a refined technique for trapping and manipulating nanoparticles, researchers at NIST have extended the trapped particles' useful life more than tenfold.

3 May 2012